Ankylose This! Living with Ankylosing Spondylitis

Thursday, January 03, 2008

Nor New Zealand

Pharmac, New Zealand's state pharmaceutical plan, covers TNF inhibitors for rheumatoid arthritis, but not for ankylosing spondylitis or psoriatic arthritis. On its face, this looks less like pushback against the high cost of TNF blockers and more like taking a long time to approve it for diseases other than rheumatoid arthritis (which is usually the first disease these things get approved for).

Labels: , ,

Comments on this post

Post a Comment

Links to this post

Create a Link